Last Updated on eMC 07-02-2018 View medicine  | Otsuka Pharmaceuticals (UK) Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Improved presentation of PIL

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Reasons for adding or updating:

  • Change to section 3 - how to take/use

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Reasons for adding or updating:

  • Change to section 3 - how to take/use
  • Change to section 6 - what the product looks like and pack contents

Reasons for adding or updating:

  • Change to information for healthcare professionals

Reasons for adding or updating:

  • Change to information for healthcare professionals

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Reasons for adding or updating:

  • New PIL for new product